Organization
Omeros Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Omeros Corp.
... Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing ...
... SEATTLE - Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its third quarter ...
... Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its third quarter ...
... Omeros Corporation(NASDAQ: OMER) today announced that extended follow-up data from patients with immunoglobulin A ...
... Omeros Corporation (NASDAQ: OMER) today announced that a subset of data will be presented ...
... SEATTLE - Omeros Corporation (NASDAQ: OMER) today announced the presentation of a case report of a ...
... Omeros Corporation(NASDAQ: OMER) today announced the presentation of a case report of a patient ...
... Omeros Corporation (NASDAQ: OMER) today announced that data will be presented from the company's ...
... If you want a Stock Review on TSRO, TRVN, OMER, or RDUS then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... SEATTLE - Omeros Corporation (NASDAQ: OMER) today announced that it entered into a settlement agreement with ...
... Omeros Corporation(NASDAQ: OMER) today announced that it entered into a settlement agreement with Par ...
... Omeros has defended the data supporting its mooted rival to Soliris after STAT ...
... Omeros Corporation (NASDAQ:OMER) stated today that it continues to pursue legal action to hold ...
... Omeros Corporation (NASDAQ: OMER) today announced that on August 18, 2017, as scheduled, it ...
... If you want a Stock Review on OCUL, OMER, OVAS, or RGLS then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... SEATTLE - Omeros Corporation (NASDAQ: OMER), a commercial stage biopharmaceutical company committed to discovering, developing and ...
... Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing ...
... Omeros Corporation(NASDAQ: OMER) today announced additional follow-up data from patients with immunoglobulin A (IgA) ...
... Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing ...
... SEATTLE - Omeros Corporation (NASDAQ: OMER), a commercial stage biopharmaceutical company committed to discovering, developing and ...
... Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing ...
... Omeros Corporation (NASDAQ:OMER) today announced thatOMS721 has received orphan drug designation from the U.S. ...
... SEATTLE - Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its second quarter ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤